1689397

9780896039384

Targets for Cancer Chemotherapy Transcription Factors and Other Nuclear Proteins

Targets for Cancer Chemotherapy Transcription Factors and Other Nuclear Proteins
$48.77
$3.95 Shipping
List Price
$165.00
Discount
70% Off
You Save
$116.23

  • Condition: New
  • Provider: Bookjunction
  • Provider Rating:
    73%
  • Ships From: STERLING HEIGHTS, MI
  • Shipping: Standard
  • Comments: New, US edition. Satisfaction guaranteed!!

seal  
  • ISBN-13: 9780896039384
  • ISBN: 0896039382
  • Publication Date: 2002
  • Publisher: Humana Press

AUTHOR

La Thangue, Nicholas B., Schussler, Jennifer, Bandara, Lasantha R.

SUMMARY

In Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins, a panel of leading basic researchers, pharmaceutical scientists, and clinical oncologists explain in detail the therapeutically-relevant protein targets that contribute to cancer pathology and spell out their implications for cancer drug discovery and clinical application. The authors identify and illuminate selected transcription factor oncoproteins and tumor suppressors, together with nuclear proteins that are central to the phenotype of the tumor cell involved in chromatin control. The emphasis is on new targets and approaches to cancer treatment derived from the cancer cell cycle, gene control targets, and angiogenesis.La Thangue, Nicholas B. is the author of 'Targets for Cancer Chemotherapy Transcription Factors and Other Nuclear Proteins', published 2002 under ISBN 9780896039384 and ISBN 0896039382.

[read more]

Questions about purchases?

You can find lots of answers to common customer questions in our FAQs

View a detailed breakdown of our shipping prices

Learn about our return policy

Still need help? Feel free to contact us

View college textbooks by subject
and top textbooks for college

The ValoreBooks Guarantee

The ValoreBooks Guarantee

With our dedicated customer support team, you can rest easy knowing that we're doing everything we can to save you time, money, and stress.